RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA – May 07, 2020: CluePoints, the premier provider of Risk-Based…
Gemma TelferMay 7, 2020
Join our next webinar to learn first-hand how the CluePoints and Parexel partnership is driving best-in-class Risk-Based Quality Management Strategies to support clinical development. This…
Gemma TelferApril 30, 2020
King of Prussia, PA – April 14, 2020: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials,…
Gemma TelferApril 14, 2020
On Tuesday, March 31, 2020, CluePoints delivered a webinar centred around the critical importance of early risk detection. Our presenter also shared insights on how…
Gemma TelferApril 7, 2020
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA – April 06, 2020: CluePoints, the premier provider of Risk-Based…
Gemma TelferApril 6, 2020
We're delighted to announce that the recording for our COVID-19 webinar has been posted! The clinical research industry is in the midst of adopting Risk-Based…
Gemma TelferApril 1, 2020
As advised in the coronavirus guidances recently issued by FDA, EMA, and MHRA, it is important to perform a fresh risk assessment for each study…
Gemma TelferMarch 30, 2020
MITIGATING THE IMPACT ON SITE MONITORING EFFORTS DUE TO COVID-19 King of Prussia, PA – March 18, 2020: CluePoints, the premier provider of Risk-Based Trial…
Gemma TelferMarch 18, 2020
Please join us for our March 31, 2020 webinar: RBQM Insights - Understanding the Critical Importance of Early Risk Detection (With a Special Feature Addressing…
Gemma TelferMarch 17, 2020
Risk-based quality management (RBQM) solutions offer sponsors and CROs a better way of detecting and managing risks that may impact the outcome of clinical trials.…
Gemma TelferFebruary 25, 2020